Omada Health Inc

Research Omada Health Inc (OMDA) on Bullrun: market cap USD 1.45B, P/E 363.8. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is USD 1.45B; P/E is 363.8.

Peer valuation comparison

Latest P/E is 363.83x versus a Healthcare sector median of 24.46x (1387.5% above).

Latest P/E is 363.83x versus a United States median of 24.87x (1363.2% above).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025USD 260.21M-USD 12.78MUSD 16.93M65.7%-0.35USD 222.04MUSD 0USD 229.68M
FY2024USD 169.80M-USD 47.14M-USD 34.78M60.6%-6.11USD 76.39MUSD 29.77M-USD 384.40M
FY2023USD 122.78M-USD 67.51M-USD 50.15M57.0%-9.52USD 115.64Mn/a-USD 350.11M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-25USD 1.45B363.8n/an/a
20252025-12-31USD 922.01Mn/an/an/a

About Omada Health Inc

Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs. It also delivers virtual care.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Omada Health Inc's market cap?

Omada Health Inc's market capitalization is USD 1.45B.

What is Omada Health Inc's P/E ratio?

Omada Health Inc's price-to-earnings (P/E) ratio is 363.8.

What does Omada Health Inc do?

Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs. It also delivers virtual care.